{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:14:51Z","timestamp":1790788491328,"version":"4.1.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005874","name":"Universit\u00e0 degli Studi G. d\u2019Annunzio Chieti - Pescara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00066","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T12:05:53Z","timestamp":1517573153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["P2Y12 Receptors in Tumorigenesis and Metastasis"],"prefix":"10.3389","volume":"9","author":[{"given":"Patrizia","family":"Ballerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Dovizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2016.01.009","article-title":"Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.","volume":"373","author":"Ai","year":"2016","journal-title":"Cancer Lett."},{"key":"B2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/09537109409005523","article-title":"Platelets and ectonucleotidases.","volume":"5","author":"Bakker","year":"1994","journal-title":"Platelets"},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/09537100903470298","article-title":"The effect of P2Y-mediated platelet activation on the release of vegf and endostatin from platelets.","volume":"21","author":"Bambace","year":"2010","journal-title":"Platelets"},{"key":"B4","doi-asserted-by":"publisher","first-page":"C267","DOI":"10.1152\/ajpcell.1999.276.1.C267","article-title":"Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase.","author":"Beigi","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(16)30168-2","article-title":"PO-35 - Designing of the new antithrombotic, and also anticancer gold complexes.","author":"Benkli","year":"2016","journal-title":"Thromb. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statement.","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"B7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves.","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharm. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signaling in the cardiovascular system.","volume":"6","author":"Burnstock","year":"2017","journal-title":"Circ. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","article-title":"Purinergic signalling and immune cells.","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","article-title":"Purinergic signalling and cancer.","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal."},{"key":"B11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y(12) inhibitors.","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1160\/THS10-11-0742","article-title":"Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate.","author":"Cattaneo","year":"2011","journal-title":"Thromb. Haemost."},{"key":"B13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5482\/HAMO-14-09-0044","article-title":"The platelet P2 receptors in inflammation.","volume":"3","author":"Cattaneo","year":"2015","journal-title":"Hamostaseologie"},{"key":"B14","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V80.11.2787.2787","article-title":"Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.","volume":"80","author":"Cattaneo","year":"1992","journal-title":"Blood"},{"key":"B15","first-page":"13","article-title":"New insights into the role of P2Y1 in platelet function.","volume":"87","author":"Cattaneo","year":"2002","journal-title":"Haematologica"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance.","volume":"63","author":"Cattaneo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10555-017-9701-1","article-title":"Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.","volume":"36","author":"Chen","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1182\/blood-2017-02-769893","article-title":"Role of ADP receptors on platelets in the growth of ovarian cancer.","volume":"130","author":"Cho","year":"2017","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5483\/BMBRep.2016.49.9.069","article-title":"Suppression of Akt-HIF-1\u03b1 signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis.","volume":"49","author":"Choi","year":"2016","journal-title":"BMB Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s00018-017-2536-7","article-title":"Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.","volume":"74","author":"Contursi","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood-2006-03-006338","article-title":"Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization.","volume":"108","author":"Cosemans","year":"2006","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.bjp.0705639","article-title":"Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1\/ERK2 and phosphatidylinositol 3-kinase signalling and cell proliferation in serum-deprived and nonstarved glioma C6 cells.","volume":"141","author":"Czajkowski","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0014-5793(02)02255-X","article-title":"ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12).","volume":"513","author":"Czajkowski","year":"2002","journal-title":"FEBS Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jth.13197","article-title":"Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry.","volume":"14","author":"Danese","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"B25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action.","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis.","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00395-009-0073-8","article-title":"Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.","volume":"105","author":"Diehl","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/12447","article-title":"Targeted disruption of cd39\/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.","volume":"5","author":"Enjyoji","year":"1999","journal-title":"Nat. Med."},{"key":"B29","year":"2015","journal-title":"Plavix (clopidogrel): Drug Safety Communication \u2013 Long-term Treatment Does Not Change Risk of Death"},{"key":"B30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCRESAHA.111.300271","article-title":"Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.","volume":"112","author":"Fitzgerald","year":"2013","journal-title":"Circ. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11302-012-9303-x","article-title":"P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.","volume":"8","author":"Gachet","year":"2012","journal-title":"Purinergic Signal."},{"key":"B32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/BJ20100166","article-title":"Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.","volume":"429","author":"Garcia","year":"2010","journal-title":"Biochem. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"32462","DOI":"10.18632\/oncotarget.8655","article-title":"Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.","volume":"7","author":"Guillem-Llobat","year":"2016","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00411-z","article-title":"Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.","volume":"8","author":"Haemmerle","year":"2017","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides.","volume":"9","author":"Haynes","year":"2006","journal-title":"Nat. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","article-title":"Purinergic receptors in thrombosis and inflammation. Arterioscler.","volume":"35","author":"Hechler","year":"2015","journal-title":"Thromb. Vasc. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs.","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/sj.bjp.0704114","article-title":"The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.","volume":"133","author":"Jin","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1523\/JNEUROSCI.5589-07.2008","article-title":"P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain.","volume":"28","author":"Kobayashi","year":"2008","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/glia.22373","article-title":"Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury.","volume":"60","author":"Kobayashi","year":"2012","journal-title":"Glia"},{"key":"B41","first-page":"4710","article-title":"Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-C]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.","author":"Kohga","year":"1981","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40264-016-0481-2","article-title":"Cancer event rate and mortality with thienopyridines: a systematic review and meta-analysis.","volume":"40","author":"Kotronias","year":"2017","journal-title":"Drug Saf."},{"key":"B43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1471-4892(03)00007-9","article-title":"Platelet purinergic receptors.","volume":"3","author":"Kunapuli","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.amjmed.2017.01.022","article-title":"The effect of combined aspirin and clopidogrel treatment on cancer incidence.","volume":"130","author":"Leader","year":"2017","journal-title":"Am. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/glia.22355","article-title":"\u03b2-arrestin 2-dependent activation of ERK1\/2 is required for ADP-induced paxillin phosphorylation at Ser(83) and microglia chemotaxis.","volume":"60","author":"Lee","year":"2012","journal-title":"Glia"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1161\/01.ATV.0000092127.16125.E6","article-title":"Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.","volume":"23","author":"Leon","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0049-3848(99)00015-8","article-title":"Platelet dense granules: structure, function and implications for haemostasis.","volume":"95","author":"McNicol","year":"1999","journal-title":"Thromb. Res."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139805","article-title":"Purinergic P2Y12 receptor activation in eosinophils and the schistosomal host response.","volume":"10","author":"Muniz","year":"2015","journal-title":"PLOS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/ATVBAHA.116.308725","article-title":"P2Y(12) promotes migration of vascular smooth muscle cells through cofilin dephosphorylation during atherogenesis.","volume":"37","author":"Niu","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1172\/JCI117835","article-title":"An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb\u2013IIIa complex function.","volume":"95","author":"Nurden","year":"1995","journal-title":"J. Clin. Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/glia.20963","article-title":"P2Y12 receptor-mediated integrin-beta1 activation regulates microglial process extension induced by ATP.","volume":"58","author":"Ohsawa","year":"2010","journal-title":"Glia"},{"key":"B52","doi-asserted-by":"publisher","first-page":"26266","DOI":"10.1074\/jbc.M402032200","article-title":"ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation.","volume":"279","author":"Oury","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/25\/44\/445101","article-title":"Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery.","volume":"25","author":"Pandey","year":"2014","journal-title":"Nanotechnology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and Cancer.","volume":"68","author":"Patrignani","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002599","article-title":"Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase.","volume":"3","author":"Pellegatti","year":"2008","journal-title":"PLOS ONE"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis.","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","article-title":"The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance.","volume":"2","author":"Robson","year":"2006","journal-title":"Purinergic Signal."},{"key":"B58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0567-y","article-title":"P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.","volume":"30","author":"Sarangi","year":"2013","journal-title":"Med. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"28648","DOI":"10.1074\/jbc.M704358200","article-title":"Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin \u03b1IIb\u03b23 adhesive function in platelets.","volume":"282","author":"Schoenwaelder","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1472-8206.2011.00986.x","article-title":"Pharmacokinetic basis of the antiplatelet action of prasugrel.","volume":"26","author":"Schr\u00f6r","year":"2012","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.amjcard.2015.06.026","article-title":"Survival after solid cancers in antithrombotic trials.","volume":"116","author":"Serebruany","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jcin.2013.06.011","article-title":"Response variability to P2Y12 receptor inhibitors: expectations and reality.","volume":"6","author":"Siller-Matula","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"B66","doi-asserted-by":"publisher","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","article-title":"Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.","volume":"109","author":"Sitia","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1172\/JCI38576","article-title":"The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.","volume":"122","author":"Su","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuroscience.2016.01.008","article-title":"Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.","volume":"318","author":"Swiatkowski","year":"2016","journal-title":"Neuroscience"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1177\/0022034516647713","article-title":"Involvement of microglial P2Y12 signaling in tongue cancer pain.","volume":"95","author":"Tamagawa","year":"2016","journal-title":"J. Dent. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1160\/TH14-12-1068","article-title":"Effect of P2Y12 inhibitors on inflammation and immunity.","volume":"114","author":"Thomas","year":"2015","journal-title":"Thromb. Haemost."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-5-16","article-title":"P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells.","volume":"5","author":"Wang","year":"2004","journal-title":"BMC Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ejphar.2016.09.027","article-title":"SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis.","volume":"791","author":"Wang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080780","article-title":"Platelet P2Y12 is involved in murine pulmonary metastasis.","volume":"8","author":"Wang","year":"2013","journal-title":"PLOS ONE"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/cncr.29258","article-title":"The past, present, and future of cancer incidence in the United States: 1975 through 2020.","volume":"121","author":"Weir","year":"2015","journal-title":"Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/iub.1406","article-title":"The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways.","volume":"67","author":"Wu","year":"2015","journal-title":"IUBMB Life"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-016-2759-1","article-title":"Hypoxia-induced resistance to cisplatin-mediated apoptosis in osteosarcoma cells is reversed by gambogic acid independently of HIF-1\u03b1.","volume":"420","author":"Zhao","year":"2016","journal-title":"Mol. Cell. Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:19:05Z","timestamp":1751289545000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":76,"alternative-id":["10.3389\/fphar.2018.00066"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00066","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"article-number":"66"}}